Manuel Cuenca‐Estrella

Author

Also Known As

B. Almirante, Cuenca-Estrella, M., G. Sybren De Hoog, J. T. Silva, M Cuenca-Estrella, M. Cuenca-Estrella, Manuel Cuenca-Estrella, Manuel Cuenca‐Estrella

269

Publications

27.9K

Citations

H-Index

121

Concepts

All Affiliations

Instituto de Salud Carlos III Centro Nacional de Microbiologia Hospital General Universitario Gregorio Marañón Innsbruck Medical University Statens Serum Institut

About

Manuel Cuenca‐Estrella is an author at Instituto de Salud Carlos III specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	57	107	12.8K
2	Health Sciences	27	33	2.7K
3	Natural Sciences	3	3	283
4	Engineering	2	2	119
5	Management	1	1	21

Manuel Cuenca‐Estrella

174

Publications

24.9K

Citations

H-Index

Page 1

	Year	Citations
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium J. Peter Donnelly, Sharon Chen, Carol A. Kauffman, Clinical Infectious Diseases	2019	2.6K
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Marina Pollán, Beatriz Pérez‐Gómez, Roberto Pastor‐Barriuso, The Lancet Virus EpidemiologyCovid-19 PandemicDisease SurveillanceEmerging Infectious DiseaseCovid-19 Epidemiology	2020	1.9K
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline Andrew J. Ullmann, José María Aguado, David W. Denning, Clinical Microbiology and Infection Diagnostic MycologyDiagnosisPathologyClinical MycologyExecutive Summary	2018	1.5K
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients Oliver A. Cornely, Matteo Bassetti, Thierry Calandra, Clinical Microbiology and Infection Diagnostic MycologyTranslational MedicineNon-neutropenic Adult PatientsVaginitisCandida Diseases 2012	2012	1.2K
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 Oliver A. Cornely, Éric Dannaoui, Andreas H. Groll, Clinical Microbiology and Infection Clinical MycologyDermatologyMucormycosis 2013	2014	846
Epidemiology and Predictors of Mortality in Cases of <i>Candida</i> Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 Benito Almirante, Dolors Rodríguez-Pardo, Benjamin J. Park, Journal of Clinical Microbiology Infectious Disease EpidemiologyEpidemiological TrendHealthcare-associated InfectionClinical EpidemiologyClinical Infection	2005	566
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others Anna Maria Tortorano, Malcolm Richardson, Emmanuel Roilides, Clinical Microbiology and Infection Diagnostic MycologyFungal PathogenPathologyClinical MycologyDermatology	2014	498
A New <i>Aspergillus fumigatus</i> Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of <i>cyp51A</i> Alterations Emilia Mellado, Guillermo García‐Effrón, Laura Alcázar‐Fuoli, Antimicrobial Agents and Chemotherapy	2007	489
EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST) Maiken Cavling Arendrup, Manuel Cuenca‐Estrella, Cornelia Lass‐Flörl, Clinical Microbiology and Infection Antifungal AgentAntifungal AgentsMedicineBioanalysisYeasts Edef 7.2	2012	449
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures Manuel Cuenca‐Estrella, Paul E. Verweij, Maiken Cavling Arendrup, Clinical Microbiology and Infection Diagnostic MycologyDiagnostic ProceduresDiagnosisVaginitisPathology	2012	393

Page 1